USA flag logo/image

An Official Website of the United States Government

Company Information:

Company Name:
CANCER TARGETED TECHNOLOGY, LLC
Address:
14241 NE Woodinville-Duvall Road #143
Woodinville, WA 98072-
Phone:
N/A
URL:
N/A
EIN:
120421793
DUNS:
829368690
Number of Employees:
N/A
Woman-Owned?:
No
Minority-Owned?:
No
HUBZone-Owned?:
No

Commercialization:

Has been acquired/merged with?:
N/A
Has had Spin-off?:
N/A
Has Had IPO?:
N/A
Year of IPO:
N/A
Has Patents?:
N/A
Number of Patents:
N/A
Total Sales to Date $:
$ 0.00
Total Investment to Date $
$ 0.00
POC Title:
N/A
POC Name:
N/A
POC Phone:
N/A
POC Email:
N/A
Narrative:
N/A

Award Totals:

Program/Phase Award Amount ($) Number of Awards
SBIR Phase I $307,641.00 1
SBIR Phase II $1,145,108.00 1

Award List:

Development of a novel PET imaging agent for prostate cancer

Award Year / Program / Phase:
2010 / SBIR / Phase I
Award Amount:
$307,641.00
Agency:
HHS
Principal Investigator:
Abstract:
DESCRIPTION (provided by applicant): PSMA is an important biomarker for prostate cancer prognosis and an appropriate target for therapy due to its restricted expression mainly on late-stage, androgen-independent and metastatic prostate cancer cells. While currently there is only one clinical PSMA… More

Development of a novel PET imaging agent for prostate cancer

Award Year / Program / Phase:
2011 / SBIR / Phase II
Award Amount:
$1,145,108.00
Agency:
HHS
Principal Investigator:
Beatrice Langton-webster – 206-617-0699
Abstract:
DESCRIPTION (provided by applicant): PSMA is an important biomarker for prostate cancer prognosis and an appropriate target for therapy due to its restricted expression mainly on late-stage, androgen-independent and metastatic prostate cancer cells. Whilecurrently there is only one clinical PSMA… More